ERG/5-HTP in Fragile X Syndrome (FXS)

Clinical trial NCT05030129 · COMPLETED

Trial details

NCT number: NCT05030129
Sponsor: Elizabeth Berry-Kravis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2021-10-07
Primary completion: 2023-01-19
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.